We are live on ! Find out more
IMDZ

Immune Design Corp.
IMDZ

Delisted

IMDZ was delisted on the 1st of April, 2019.

Back to rankings

61 hedge funds and large institutions have $128M invested in Immune Design Corp. in 2017 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 11 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

145% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 11

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

46% more capital invested

Capital invested by funds: $87.6M → $128M (+$40.7M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

5% more funds holding

Funds holding: 58 → 61 (+3)

Holders
61
Holders Change
+3
Holders Change %
+5.17%
% of All Funds
1.52%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
11
Increased
27
Reduced
11
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BCPEM
Bain Capital Public Equity Management
Massachusetts
+$2.18M
2
JP Morgan Chase
JP Morgan Chase
New York
+$2.02M
3
SAM
Sectoral Asset Management
Quebec, Canada
+$1.18M
4
NI
Numeric Investors
Massachusetts
+$1.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.01M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$8.39M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.13M
3
OAM
Oxford Asset Management
United Kingdom
-$377K
4
WMSA
Weiss Multi-Strategy Advisers
New York
-$340K
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$237K
Name Holding Trade Value Shares
Change 		Change in
Stake
VVM
1
Versant Venture Management
California
$21.3M – – –
Victory Capital Management
2
Victory Capital Management
Texas
$19.3M +$281K +40,010 +2%
PAI
3
ProQuest Associates IV
Florida
$19.1M – – –
BlackRock
4
BlackRock
New York
$10.1M +$982K +139,914 +16%
Franklin Resources
5
Franklin Resources
California
$7.41M +$140K +20,000 +3%
JP Morgan Chase
6
JP Morgan Chase
New York
$5.17M +$2.02M +288,009 +119%
Vanguard Group
7
Vanguard Group
Pennsylvania
$5.12M +$1.01M +144,408 +38%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$4.01M -$237K -33,811 -8%
BCPEM
9
Bain Capital Public Equity Management
Massachusetts
$3.8M +$2.18M +310,433 +393%
A
10
Abingworth
United Kingdom
$3.4M – – –
CAM
11
Cormorant Asset Management
Massachusetts
$3.29M – – –
State Street
12
State Street
Massachusetts
$2.18M -$6.96K -992 -0.4%
Wells Fargo
13
Wells Fargo
California
$2.13M +$490K +69,813 +47%
PAM
14
Panagora Asset Management
Massachusetts
$2.05M +$496K +70,734 +51%
Northern Trust
15
Northern Trust
Illinois
$1.76M +$313K +44,653 +33%
NI
16
Numeric Investors
Massachusetts
$1.64M +$1.18M +168,290 New
SAM
17
Sectoral Asset Management
Quebec, Canada
$1.64M +$1.18M +168,300 New
BBA
18
Baker Bros. Advisors
New York
$1.45M – – –
Millennium Management
19
Millennium Management
New York
$1.41M -$71.7K -10,211 -7%
Renaissance Technologies
20
Renaissance Technologies
New York
$1.36M +$197K +28,060 +25%
NFA
21
Nationwide Fund Advisors
Ohio
$1.34M +$892K +127,100 +1,198%
BCM
22
Bridgeway Capital Management
Texas
$1.12M – – –
Geode Capital Management
23
Geode Capital Management
Massachusetts
$1.08M +$52.2K +7,436 +7%
Deutsche Bank
24
Deutsche Bank
Germany
$782K +$238K +33,850 +73%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$773K +$123K +17,563 +28%
1
2 3

IMDZ Hedge Fund Activity: Q2 2017 in Review

61 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2017, worth a combined $128M — up 46% from $87.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IMDZ positions and 8 closed out — a net gain of 3 holders — while 27 added to existing stakes and 11 trimmed.

The largest buyer was Bain Capital Public Equity Management, adding an estimated $2.18M. The largest seller was BVF Inc, exiting entirely with an estimated $8.39M sold.

  • 61 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2017, up from 58 in Q1 2017.
  • Funds reported $128M of Immune Design Corp. stock for Q2 2017, up 46% quarter-over-quarter.
  • 11 funds opened new Immune Design Corp. positions in Q2 2017 and 8 closed out, a net change of +3 holders.
  • The largest Immune Design Corp. buyer in Q2 2017 was Bain Capital Public Equity Management, an estimated $2.18M added.
  • The largest Immune Design Corp. seller in Q2 2017 was BVF Inc, an estimated $8.39M sold.

Based on aggregated 13F filings for Q2 2017.